NEURONETICS INC. news, videos and press releases
For more news please use our advanced search feature.
NEURONETICS INC. - More news...
NEURONETICS INC. - More news...
- Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
- Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
- Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
- Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
- New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
- Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
- Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
- Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
- Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
- NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
- Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
- Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
- NeuroStar TMS Receives Expanded Regulatory Approval in Japan
- Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference
- NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
- Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
- Neuronetics Reports Third Quarter 2023 Financial and Operating Results
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call
- Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
- Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility
- In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
- NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
- Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
- Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)